» Articles » PMID: 26138947

Nursing Home and End-of-life Care in Parkinson Disease

Overview
Journal Neurology
Specialty Neurology
Date 2015 Jul 4
PMID 26138947
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine long-term care facility (LTCF or nursing home) use and end-of-life care for individuals with Parkinson disease (PD).

Methods: In this nationwide retrospective cohort study, we compared LTCF and hospice utilization among Medicare beneficiaries diagnosed with PD by demographic, clinical, and physician characteristics. We also examined the impact of outpatient neurologist care for institutionalized patients with PD on end-of-life care.

Results: We identified 469,055 individuals with PD who received Medicare benefits in 2002. Nearly 25% (more than 100,000 in total) resided in an LTCF. Women with PD had greater odds of nursing facility residence (adjusted odds ratio [AOR] 1.34, 95% confidence interval [CI] 1.30-1.38) compared with men. Black individuals with PD were 34% more likely than white individuals to reside in an LTCF (AOR 1.34, 95% CI 1.30-1.38), contrary to the race patterns typically observed for LTCF use. Hip fracture (AOR 2.10, 95% CI 2.04-2.15) and dementia (AOR 4.06, 95% CI 4.00-4.12) were the strongest clinical predictors of LTCF placement. Only 33% (n = 38,334) of nursing home residents with PD had outpatient neurologist care. Eighty-four percent (n = 80,877) of LTCF residents with PD died by December 31, 2005. Hospice utilization varied little by race and sex. LTCF residents who had outpatient neurologist care were twice as likely to utilize hospice services before death (AOR 2.35, 95% CI 2.24-2.47).

Conclusions And Relevance: A large proportion of the Medicare PD population resides in an LTCF. There is substantial unmet need for palliative care in the PD population. Increased efforts to provide specialist care to dependent individuals with PD may improve end-of-life care.

Citing Articles

Hospice Use Among Medicare Beneficiaries With Parkinson Disease and Dementia With Lewy Bodies.

Bock M, Gan S, Aldridge M, Harrison K, Yaffe K, Smith A JAMA Netw Open. 2025; 8(3):e250014.

PMID: 40036035 PMC: 11880951. DOI: 10.1001/jamanetworkopen.2025.0014.


Integrating Big Data, Artificial Intelligence, and motion analysis for emerging precision medicine applications in Parkinson's Disease.

Dipietro L, Eden U, Elkin-Frankston S, El-Hagrassy M, Camsari D, Ramos-Estebanez C J Big Data. 2024; 11(1):155.

PMID: 39493349 PMC: 11525280. DOI: 10.1186/s40537-024-01023-3.


Health care utilization at the end of life in Parkinson's disease: a population-based register study.

Leavy B, Akesson E, Lokk J, Schultz T, Strang P, Franzen E BMC Palliat Care. 2024; 23(1):251.

PMID: 39468712 PMC: 11520450. DOI: 10.1186/s12904-024-01581-6.


Emerging perspectives on precision therapy for Parkinson's disease: multidimensional evidence leading to a new breakthrough in personalized medicine.

Wang Q, Gu X, Yang L, Jiang Y, Zhang J, He J Front Aging Neurosci. 2024; 16:1417515.

PMID: 39026991 PMC: 11254646. DOI: 10.3389/fnagi.2024.1417515.


Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics.

Rajagopalan K, Rashid N, Gopal D, Doshi D J Comp Eff Res. 2024; 13(7):e240038.

PMID: 38850129 PMC: 11225156. DOI: 10.57264/cer-2024-0038.


References
1.
Willis A, Schootman M, Kung N, Wang X, Perlmutter J, Racette B . Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 2013; 82(2):163-71. PMC: 3897433. DOI: 10.1212/WNL.0000000000000017. View

2.
Teresi J, Albert S, Holmes D, Mayeux R . Use of latent class analyses for the estimation of prevalence of cognitive impairment, and signs of stroke and Parkinson's disease among African-American elderly of central Harlem: results of the Harlem Aging Project. Neuroepidemiology. 1999; 18(6):309-21. DOI: 10.1159/000026226. View

3.
Christakis N, Iwashyna T . Impact of individual and market factors on the timing of initiation of hospice terminal care. Med Care. 2000; 38(5):528-41. DOI: 10.1097/00005650-200005000-00009. View

4.
Aarsland D, Larsen J, Tandberg E, Laake K . Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc. 2000; 48(8):938-42. DOI: 10.1111/j.1532-5415.2000.tb06891.x. View

5.
Weintraub D, Raskin A, Ruskin P, Gruber-Baldini A, Zimmerman S, Hebel J . Racial differences in the prevalence of dementia among patients admitted to nursing homes. Psychiatr Serv. 2000; 51(10):1259-64. DOI: 10.1176/appi.ps.51.10.1259. View